Cargando…

Synergistic effect of vancomycin combined with cefotaxime, imipenem, or meropenem against Staphylococcus aureus with reduced susceptibility to vancomycin

BACKGROUND/AIM: We investigated the synergistic effect between vancomycin and β-lactams against vancomycin-susceptible (VSSA) and nonsusceptible MRSA isolates [heterogeneous vancomycin-intermediate S. aureus (hVISA) and VISA]. MATERIALS AND METHODS: A total of 29 MRSA, including 6 VISA, 14 hVISA, an...

Descripción completa

Detalles Bibliográficos
Autores principales:	SRİSRATTAKARN, Arpasiri, CHAİYAPOKE, Chonthicha, BOONCHAROEN, Sirikarn, WONGTHONG, Sujintana, CHANAWONG, Aroonwadee, TİPPAYAWAT, Patcharaporn, TAVİCHAKORNTRAKOOL, Ratree, LULİTANOND, Aroonlug
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Scientific and Technological Research Council of Turkey 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569772/ https://www.ncbi.nlm.nih.gov/pubmed/33705643 http://dx.doi.org/10.3906/sag-1910-166

Ejemplares similares

Rapid detection of Enterococcus and vancomycin resistance using recombinase polymerase amplification
por: Panpru, Pimchanok, et al.
Publicado: (2021)

Phenotypic Characteristics of Vancomycin-Non-Susceptible Staphylococcus aureus
por: Sirichoat, Auttawit, et al.
Publicado: (2016)

Development of a Prototype Lateral Flow Immunoassay for Rapid Detection of Staphylococcal Protein A in Positive Blood Culture Samples
por: Srisrattakarn, Arpasiri, et al.
Publicado: (2020)

Rapid detection of methicillin-resistant Staphylococcus aureus in positive blood-cultures by recombinase polymerase amplification combined with lateral flow strip
por: Srisrattakarn, Arpasiri, et al.
Publicado: (2022)

Recombinase Polymerase Amplification Combined with Lateral Flow Strip for Rapid Detection of OXA-48-like Carbapenemase Genes in Enterobacterales
por: Hemwaranon, Phatsarawadee, et al.
Publicado: (2022)

Inhibition of Bacterial Efflux Pumps by Crude Extracts and Essential Oil from Myristica fragrans Houtt. (Nutmeg) Seeds against Methicillin-Resistant Staphylococcus aureus
por: Oo, Thidar, et al.
Publicado: (2021)

Colistin heteroresistance in carbapenem-resistant Acinetobacter baumannii clinical isolates from a Thai university hospital
por: Thet, Khin Thet, et al.
Publicado: (2020)

Anti-Proteus Activity, Anti-Struvite Crystal, and Phytochemical Analysis of Sida acuta Burm. F. Ethanolic Leaf Extract
por: Smanthong, Nitis, et al.
Publicado: (2022)

Multi Evaluation of a Modified GoldNano Carb Test for Carbapenemase Detection in Clinical Isolates of Gram-Negative Bacilli
por: Srisrattakarn, Arpasiri, et al.
Publicado: (2022)

No Resistance to Penicillin, Cefuroxime, Cefotaxime, or Vancomycin in Pneumococcal Pneumonia
por: Yayan, Josef, et al.
Publicado: (2015)

Effects of Escherichia coli and Proteus mirabilis on the Growth and Aggregation of Calcium Oxalate Crystal under Microaerobic Conditions
por: Saelee, Krittaya, et al.
Publicado: (2022)

Acute Kidney Injury in Pediatric Patients Treated with Vancomycin and Piperacillin-Tazobactam Versus Vancomycin and Cefotaxime: A Single-center Study
por: Alqurashi, Rewaa, et al.
Publicado: (2020)

Risk factors for canine magnesium ammonium phosphate urolithiasis associated with bacterial infection
por: Uttamamul, Nahathai, et al.
Publicado: (2021)

(1)H NMR metabolic profiling of Staphylococcus pseudintermedius isolated from canine uroliths
por: Uttamamul, Nahathai, et al.
Publicado: (2022)

Empirical cefepime+vancomycin versus ceftazidime+vancomycin versus meropenem+vancomycin in the treatment of healthcare-associated meningitis: results of the multicenter Ephesus study
por: Sipahi, Oguz Resat, et al.
Publicado: (2023)

Comparison of Rates of Acute Kidney Injury with Vancomycin/Piperacillin-Tazobactam vs. Vancomycin/Meropenem Combination Therapy
por: Pernia, Sonia, et al.
Publicado: (2017)

ST9 MRSA strains carrying a variant of type IX SCCmec identified in the Thai community
por: Lulitanond, Aroonlug, et al.
Publicado: (2013)

Population Pharmacokinetics of Vancomycin and Meropenem in Pediatric Extracorporeal Membrane Oxygenation Support
por: Zylbersztajn, Brenda, et al.
Publicado: (2021)

Elongation factor Tu on Escherichia coli isolated from urine of kidney stone patients promotes calcium oxalate crystal growth and aggregation
por: Amimanan, Piyawan, et al.
Publicado: (2017)

Comparison of Acute Kidney Injury During Treatment with Vancomycin and either Piperacillin-Tazobactam or Meropenem
por: Cannon, John M., et al.
Publicado: (2017)

Efficacy of Vancomycin and Meropenem in Central Nervous System Infections in Children and Adults: Current Update
por: Schneider, Franziska, et al.
Publicado: (2022)

Morphological and Bactericidal Effects of Amikacin, Meropenem and Imipenem on Pseudomonas aeruginosa
por: Moghoofei, Mohsen, et al.
Publicado: (2015)

Emergence of Meropenem Resistance Among Cefotaxime Non-susceptible Streptococcus pneumoniae: Evidence and Challenges
por: Varghese, Rosemol, et al.
Publicado: (2022)

Favipiravir/meropenem/vancomycin: Cholestatic liver injury following off-label use: case report
Publicado: (2021)

Cerebrospinal Fluid Concentrations of Meropenem and Vancomycin in Ventriculitis Patients Obtained by TDM-Guided Continuous Infusion
por: Tiede, Christoph, et al.
Publicado: (2021)

A randomized study of imipenem compared to cefotaxime plus piperacillin as initial therapy of infections in granulocytopenic patients
por: Böhme, Angelika, et al.
Publicado: (1995)

In vitro and in vivo activities of linezolid alone and combined with vancomycin and imipenem against Staphylococcus aureus with reduced susceptibility to glycopeptides
por: Ribes, S., et al.
Publicado: (2010)

Vancomycin-resistant enterococci: eradication using vancomycin?
por: Van Prehn, J, et al.
Publicado: (2014)

Vancomycin-Associated Tubular Casts and Vancomycin Nephrotoxicity
por: Tantranont, Ngoentra, et al.
Publicado: (2021)

In vitro activity effects of combinations of cephalothin, dicloxacillin, imipenem, vancomycin and amikacin against methicillin-resistant Staphylococcus spp. strains
por: Miranda-Novales, Guadalupe, et al.
Publicado: (2006)

The First Case of Septicemia Caused by Imipenem-Susceptible, Meropenem-Resistant Klebsiella pneumoniae
por: Kayama, Shizuo, et al.
Publicado: (2013)

Mutant Prevention Concentrations of Imipenem and Meropenem against Pseudomonas aeruginosa and Acinetobacter baumannii
por: Dahdouh, E., et al.
Publicado: (2014)

Molecular Epidemiology and Mechanisms of High-Level Resistance to Meropenem and Imipenem in Pseudomonas aeruginosa
por: Hassuna, Noha Anwar, et al.
Publicado: (2020)

Is There a Significant Difference in Acute Kidney Injury Incidence Among Patients Treated with Vancomycin Combined with Cefepime or Meropenem?
por: Rutter, W Cliff, et al.
Publicado: (2017)

Efficacy and safety of intrathecal meropenem and vancomycin in the treatment of postoperative intracranial infection in patients with severe traumatic brain injury
por: Zhang, Qiang, et al.
Publicado: (2019)

Comparison of Intravenous Microdialysis and Standard Plasma Sampling for Monitoring of Vancomycin and Meropenem Plasma Concentrations—An Experimental Porcine Study
por: Lilleøre, Johanne Gade, et al.
Publicado: (2023)

Concentrations of Co-Administered Meropenem and Vancomycin in Spinal Tissues Relevant for the Treatment of Pyogenic Spondylodiscitis—An Experimental Microdialysis Study
por: Slater, Josefine, et al.
Publicado: (2023)

Preparation, Physicochemical Characterization, Antimicrobial Effects, Biocompatibility and Cytotoxicity of Co-Loaded Meropenem and Vancomycin in Mesoporous Silica Nanoparticles
por: Yekani, Mina, et al.
Publicado: (2023)

Eradication of Vancomycin-Resistant Enterococci by Combining Phage and Vancomycin
por: Shlezinger, Mor, et al.
Publicado: (2019)

The Nephrotoxicity of Vancomycin
por: Filippone, EJ, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_lmcmcu336vo5mujlmih0gvf3e3